Mind Medicine MindMed Inc (MNMD) News

Looking better today and starting the afternoon climb which tends to result in a higher close

Still in that zone though... side ways right now. This will take off.

Shitty day yesterday..!

Got a handful today as well to add to the coffers. Today was sort of a blessing for those that may have wanted in at a decent price. Won't stay at these levels much longer. Crazy churning.

Yeah I bought a couple thousand shares between $2.60-$3.20 a share

Lots of good cheapies picked up between Q4 2022 through Q1 2024 :)

Might be hard to see this go past 60 at that high end resistance. Fingers crossed.

Look at the 5 year chart... once we go past 20.00 the ride to 40.00 is easy. 20.00 will be the hard point and is the median Price Target. However, once we go through that territory we will go past 40.00 hitting that 53.00+ Price target. This will be the second wave. First one was fun.

Yup purse strings are going to open. I hate to say that this administration will fuel that but typically conservatives do well in the markets. We are off to the races now. stack em up. What best... I actually believe in this company 8-10x easy...

10X is coming this year

Tapped 8.00+ Premarket. But that's nothing really. Next news cycle will be a banger.

It's about to go crazy, just need get a few more eyes on it. 

I honestly believe the average price target is like $40-$50 currently.

We are now past tax harvesting, moving into a good year with lots of support. We should see organic growth towards greener pastures. Good times ahead.

Yeah, we've been caught in a range for the last month. Great time for a good week and bust out if it.

Nice price and volume today!! Looks like we are heading to the $9 range this week

Crying now???

SUCH A MAMALUKE!!!!

I apologize for all of that but I will NOT be bullied off this board with immature insults and lies. I am posting accurate content,

Look, I would like to post accurate information without being called names and lied about. Everytime I do, I get attacked. I guess y’all don’t have a problem with that.

Can we be done with the bickering.... please. Keep it on track. We have a good year ahead of us. We will all do well. Relax.

I thought we had some good news, when I saw all the unread posts.. but all the postings were just a spatz bummer..

Hallelujah!!!!

You can’t backup what you said. You know what that makes you.

Ok I’m really done with this.

Cool story BRO....

You’re not making sense. You attacked me first and said I was spreading misinformation. I asked you to back up your accusation. You can’t! So you’re the one spreading misinformation. It’s all there to see. I’m done with your ignorance.

Put.Me.On.Ignore.

Lol...So, your M.O. isn't to post misleading GARBAGE??? Like only 1 subject on the "1st" subject trial....

TOTAL MAMALUKE!!!!

Here’s where you said I was posting misleading information. This post is bullshit so it’s you posting bullshit.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175621786

I am not posting untruths or misleading information. Apparently you can’t handle the truth so you attack the messenger. Just because you don’t like the information doesn’t mean it’s not true. LOL

You can’t handle the truth so please put me on ignore and let’s stop this.

I call BULLSHIT on your bullshit...

Where do you see where I posted "BULLSHIT"?

I SAID NOBODY CARES...

Exactly what did I post that was incorrect? Nothing! So, who's posting BS now? Look in the mirror. LMAO!

Post if you want...NOBODY CARES

One more thing. As I have said many times before, I am a longterm long here. I even added more shares after I got creamed by the 15-1 reverse split of August, 2022. I have noticed that only positive news and developments get posted here and it makes people good about their investments. That's great! But with developmental biotechs, there are always like bumps in the road, like large dilutions, time frames etc. & that kind of information doesn't get posted here.

Non-positive news is 50% of the the information that should be considered when one makes an investment with an always risky development biotech. ie all developmental biotechs are risky. The risk is why the upside can be gigantic. Without risk, the payoff would be, for the most part, priced in.

That's why I'm gonna continue to post here. If you don't like to hear the truth, then yes, put me on ignore or just ignore my posts. I regularly get called a "short"
and all kinds of other offensive names. The posters that are posting accusations about me are the ones who are posting the false information.

Think about that.

This is completely false. Could you please point out one incorrect thing I have posted?

So, your M.O. is to post MISLEADING GARBAGE.....GOT IT!!! Thanks for sharing

"but I’ll post here if I want."

Correct. If people think that patients are going to walk into a doctor's office and get a tab of street-grade LSD for their condition, they are beyond wrong. Like you said, MM120 is an LSD derivative. And if approved, ONLY MM120 will be allowed to be prescribed and taken by patients. Besides being a derivative, and not 100% actual LSD, there is the requirement of potency regulations concerning prescription medications/therapies. Each dose has to be free of contamination AND very consistent with the actual content of the active ingredient. There are tons of laws and regulations about the production of FDA approved drugs. You can't just cook this stuff up in your basement. Each dose has to be 100% the same as the last, and each lot has to be the same as the last. This stuff is manufactured in a laboratory-like factories with the strictest of guidelines and regulatory oversight.

For those that want to gripe about patents... chew on this:

There are several examples in the pharmaceutical industry where drugs that could not be patented at the molecular level (often because the molecule was already known or off-patent) were successfully commercialized by patenting other aspects like formulations, delivery methods, manufacturing processes, or specific uses. Here are a few notable examples:

Prozac (Fluoxetine) • Scenario: While fluoxetine as a molecule was patentable when introduced by Eli Lilly, many of its follow-on products (like Prozac Weekly) were patented not for the molecule itself but for the controlled-release formulation. • Success: Extended exclusivity allowed Eli Lilly to maintain a market presence and differentiate from generic versions.

Lyrica (Pregabalin) • Scenario: The basic pregabalin molecule was known, but Pfizer obtained patents for its specific uses (e.g., neuropathic pain and fibromyalgia) and its crystalline structure. • Success: These patents blocked competitors and supported Lyrica’s billion-dollar revenue until generics entered after the patents expired.

Adderall (Amphetamine Salt Combo) • Scenario: Amphetamine salts were long-known substances, but Shire Pharmaceuticals patented a specific formulation and delivery mechanism that allowed a controlled release, creating Adderall XR. • Success: Adderall XR became a blockbuster drug for ADHD.

Wellbutrin XL (Bupropion) • Scenario: The molecule bupropion had already been developed, but GlaxoSmithKline patented the extended-release formulation of Wellbutrin XL to improve patient compliance and reduce side effects. • Success: The reformulation allowed the drug to become widely prescribed for depression and smoking cessation.

Suboxone (Buprenorphine/Naloxone) • Scenario: Buprenorphine is an old molecule, but Indivior patented the combination therapy with naloxone and the sublingual film formulation for opioid dependence. • Success: These innovations created market exclusivity and established Suboxone as a leading treatment in its class.

Trexall (Methotrexate) • Scenario: Methotrexate is a decades-old drug, but newer versions like Trexall leveraged formulation patents for specific dosing regimens or injectable formulations. • Success: It allowed for continued use and revenue in treating autoimmune diseases and cancers.

EpiPen (Epinephrine Auto-Injector) • Scenario: Epinephrine is not patentable, but Mylan protected the auto-injector device design and delivery system. • Success: Despite controversy over pricing, EpiPen became a household name and dominated its market.

OxyContin (Oxycodone) • Scenario: Oxycodone was already known, but Purdue Pharma patented the extended-release formulation that turned it into a controlled-release painkiller. • Success: OxyContin became highly profitable (though also controversial).

Implications for MindMed

For MM-120 (LSD), MindMed’s patents on formulations, manufacturing methods, dosing protocols, and specific therapeutic applications can provide a robust IP portfolio to protect their investment. Similar to the examples above, these protections will allow them to commercialize LSD-derived therapies despite the base molecule’s lack of patentability.

5-HT2A receptor for the win!

Neumora Therapeutics Depression Drug Fails In First Of Three Pivotal Phase 3 Trials

https://finance.yahoo.com/news/neumora-therapeutics-depression-drug-fails-133028449.html

This team is bringing LSD to market... period

Gives me a chance to still load at these cheap prices!

Up great yesterday, today down.. no reason for the selling at this point.

Here comes the name calling attacks. Jack was supposed to put me on ignore after he predicted that MNMD would get bought out for
$40 billion plus by mid year 2025 and I joked that another reverse split (15 shares to 1 share) like they had in August 2022 was far more likely than his proposal. Yet, apparently he can’t figure out how to put me on ignore because… well because he’s still seeing all my posts lol

I’m done with this (for now)

lol I’m not saying they need to supply a press release for each enrollee. If we’re at one, so be it. I was under the assumption that the trial would enroll fairly quickly and it still could be.

Why did I even mention this? I was eagerly awaiting for the promised “before the end of the year” announcement of the start of the trial. They delivered that promise in the most minimal way they could and that concerned me a little.

I’m here and I’m long, but I still keep a very wary eye on any small biotechs that I’m invested in.

Some people have no clue. It is customary in clinical trials, like you say, for companies to issue a press release saying the first patient has be dosed. It's communicating that the trial has begun, nothing more. Obviously there will be many more patients/subjects. Dude is a bashturd, though. Just put him on ignore.

Not an attack,  but I think sending a press release for every dosed patient isn't realistic.  Infer as a reasonable person that the notice of first patient dosed is a kickoff notification.   Give the company some grace to run a complicated and expensive trial process without day to day press release updates that would be costly and time consuming.   The trial is estimated at an enrollment of 200. Mindmed is working.   Inventing the assumption that they are at one because that's what the last press release said is a bit unreasonable.   If it's the case i might be alarmed but it's hard for me to get there from the complete information set for this company right now.

Thanks for that. lol I’m not doubting that there is a phase III trial happening.

I just think it’s highly unusual that so far the company has shared that it has only 1 dosing. I’m pretty sure there has been more. It’s just odd that this is where we’re at. ONE.

This is not a discussion board. Any discussion is attacked.

WOW! Think you misunderstood my post.

I'm saying I'm sure there are people out there eager to be a test subject for ANY drugs that alter your mind....

Wow! I never even came close to saying that. There is a lot more to running a legitimate phase III trial than finding people who want to participate. I think the company could be a lot more open with us after all we’ve been through.

I would like this to be a discussion board. Apparently you, and most others, just want a rah rah cheerleaders board.

A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (VOYAGE) (Voyage)

https://clinicaltrials.gov/study/NCT06741228?spons=Mind%20Medicine,%20Inc.&rank=1#study-overview

LOLOLOLOL....you think it would be difficult to get "patients/enrollees" for ANY PSYCHEDELIC drug trials???

" revised number of enrollees"

Things are good? Whew! I know I feel better but I’ll post here if I want.